A broad look into the future of systemic sclerosis
Systemic sclerosis (SSc) is a systemic autoimmune disease with the key features of inflammation, vasculopathy and fibrosis. This article focussed on emerging fields based on the authors’ current work and expertise. The authors provide a hierarchical structure into the studies of the pathogenesis of...
Main Authors: | Gabriela Riemekasten, Jörg H.W. Distler |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-08-01
|
Series: | Therapeutic Advances in Musculoskeletal Disease |
Online Access: | https://doi.org/10.1177/1759720X221109404 |
Similar Items
-
Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis
by: Hanna Graßhoff, et al.
Published: (2022-09-01) -
Are tyrosine kinase inhibitors promising for the treatment of systemic sclerosis and other fibrotic diseases?
by: C Beyer, et al.
Published: (2010-08-01) -
When natural antibodies become pathogenic: autoantibodies targeted against G protein-coupled receptors in the pathogenesis of systemic sclerosis
by: Reza Akbarzadeh, et al.
Published: (2023-06-01) -
The burden of systemic sclerosis in Switzerland – the Swiss systemic sclerosis EUSTAR cohort
by: Jasmin Hernández, et al.
Published: (2021-07-01) -
Are tyrosine kinase inhibitors promising for the treatment of systemic sclerosis and other fibrotic diseases?
by: JHW Distler
Published: (2010-04-01)